Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.

Picco G, Petti C, Centonze A, Torchiaro E, Crisafulli G, Novara L, Acquaviva A, Bardelli A, Medico E
EMBO Mol Med. 2017 Mar;9(3):293-303. doi: 10.15252/emmm.201606773. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.